Publications by authors named "Motalib Smahi"

Claim this Profile
A
APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation.
Pierre Toulon, Motalib Smahi, Neila De Pooter

J Thromb Haemost· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation: Response from original authors Toulon et al.
Pierre Toulon, Motalib Smahi, Neila De Pooter

J Thromb Haemost· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in patients with non-high pre-test probability: Clinical performance and cost-effectiveness analysis.
Neila De Pooter, Marie Brionne-François, Motalib Smahi, Lien Abecassis, Pierre Toulon

J Thromb Haemost· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring unfractionated heparin therapy: Lack of standardization of anti-Xa activity reagents.
Motalib Smahi, Neila De Pooter, Martine J Hollestelle, Pierre Toulon

J Thromb Haemost· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor VIII and IX assays for post-infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).
Emmanuelle Jeanpierre, Claire Pouplard, Dominique Lasne, Véronique Le Cam Duchez, Valérie Eschwege, Motalib Smahi

Eur J Haematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Factor IX assays in treated hemophilia B patients].
Claire Pouplard, Emmanuelle Jeanpierre, Dominique Lasne, Véronique Le Cam Duchez, Valérie Eschwege, Motalib Smahi

Ann Biol Clin (Paris)· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Factor VIII assays in treated hemophilia A patients].
Dominique Lasne, Claire Pouplard, Christophe Nougier, Valérie Eschwege, Véronique Le Cam Duchez, Motalib Smahi

Ann Biol Clin (Paris)· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring treatments with unfractionated heparin: CTAD must be used instead of citrate as the anticoagulant solution when using partial-draw collection tubes. Results of a multicenter evaluation.
Pierre Toulon, Liên Abecassis, Motalib Smahi, Catherine Ternisien

Thromb Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).
Pierre Toulon, Nadine Ajzenberg, Motalib Smahi, Marie-Claude Guillin

Thromb Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis